Search research articles
Contact Us
Filters
Showing results (241-250 of 276) with videos related to
Page
of 28
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2019
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases
Ricarda Rauschenberg, Johannes Bruns, Julia Brütting, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 17, 2024
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas
Philipp Jansen, Wolfgang Galetzka, Georg C Lodde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 28, 2023
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
Anne Zaremba, Peter Mohr, Ralf Gutzmer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis
Glenn Geidel, Sabrina Bänsch, Laura Adam, et al.
Circulation. Genomic and Precision Medicine
|
March 17, 2018
Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular Dystrophy
Ibrahim El-Battrawy, Zhihan Zhao, Huan Lan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2025
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors
Oliver Bechter, Carmen Loquai, Stephane Champiat, et al.
Ebiomedicine
|
September 3, 2023
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM
Jan-Malte Placke, Mona Kimmig, Klaus Griewank, et al.
The New England Journal of Medicine
|
June 6, 2012
Improved survival with MEK inhibition in BRAF-mutated melanoma
Keith T Flaherty, Caroline Robert, Peter Hersey, et al.
Frontiers in Immunology
|
June 25, 2024
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Elias A T Koch, Anne Petzold, Edgar Dippel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2021
NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
Carl M Thielmann, Eleftheria Chorti, Johanna Matull, et al.
Page
of 28
Search research articles
Search
Showing results (241-250 of 276) with videos related to
Sort By:
Page
of 28
European Journal of Cancer (Oxford, England : 1990)
|
February 12, 2019
Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases
Ricarda Rauschenberg, Johannes Bruns, Julia Brütting, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 17, 2024
Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas
Philipp Jansen, Wolfgang Galetzka, Georg C Lodde, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 28, 2023
Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG
Anne Zaremba, Peter Mohr, Ralf Gutzmer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
January 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis
Glenn Geidel, Sabrina Bänsch, Laura Adam, et al.
Circulation. Genomic and Precision Medicine
|
March 17, 2018
Ion Channel Dysfunctions in Dilated Cardiomyopathy in Limb-Girdle Muscular Dystrophy
Ibrahim El-Battrawy, Zhihan Zhao, Huan Lan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 28, 2025
A Phase I, First-in-Human, Dose-Escalation, Expansion Trial of Cytokine-Encoding Synthetic mRNA Mixture Alone or with Cemiplimab in Advanced Solid Tumors
Oliver Bechter, Carmen Loquai, Stephane Champiat, et al.
Ebiomedicine
|
September 3, 2023
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma - analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM
Jan-Malte Placke, Mona Kimmig, Klaus Griewank, et al.
The New England Journal of Medicine
|
June 6, 2012
Improved survival with MEK inhibition in BRAF-mutated melanoma
Keith T Flaherty, Caroline Robert, Peter Hersey, et al.
Frontiers in Immunology
|
June 25, 2024
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse events
Elias A T Koch, Anne Petzold, Edgar Dippel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2021
NF1-mutated melanomas reveal distinct clinical characteristics depending on tumour origin and respond favourably to immune checkpoint inhibitors
Carl M Thielmann, Eleftheria Chorti, Johanna Matull, et al.
Page
of 28